Navigation Links
Data From Adherex's European Phase Ib/II Trial of ADH-1 to be,Presented at International Symposium on Targeted Anticancer,Therapies

is emerging as a pioneering oncology company. For more information, please visit our website at www.adherex.com.

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of clinical trials, drug development and regulatory review, the early stage of our product candidates, our reliance on collaborative partners, our need for additional capital to fund our operations, our history of losses, and other risks inherent in the biopharmaceutical industry. For a more detailed discussion of related risk factors, please refer to our public filings available at www.sedar.com and www.sec.gov.

SOURCE: Adherex Technologies Inc.

Adherex Technologies Inc.
Melissa Matson
Director, Corporate Communications
919-484-8484
matsonm@adherex.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Malvern initiates European user group meetings for chemical imaging
7. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
8. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
9. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
10. Inspire Announces Presentations at Two European Scientific Conferences
11. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association

Post Your Comments:
(Date:11/9/2009)...9, 2009 Monsanto Company...announced that they have entered into an agreement...lage Research Center located in Chesterfield, Mo. ...cquire the property from Pfizer for $435 million t...ave operations at Chesterfield Village through a l...
(Date:11/9/2009)...Va., Nov. 9 LifeNet Health, a lead...aunch of Vertigraft Cervical Bio-Implant (VG2C) wi...; is a new, proprietary glycerol-based preservatio...e stored in a fully hydrated state at ambient temp...eze-dry bio-implants, doing away with lengthy thaw...
(Date:11/9/2009)..., Nov. 9 Thomson Reuters today a...CareFocus, a leading clinical surveillance solutio...nts in real-time and respond immediately to improv...ent. ,, This upgrade is available to current Ca...areFocus 2.0 contains several powerful enhancement...
Breaking Medicine Technology:Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3LifeNet Health Announces First Bio-Implant with New Preservation Technology 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Blood flow in Alzheimers disease 52791 1Blood flow in Alzheimers disease 52791 2Nanophysics 3A Serving up Buckyballs on a silver platter 9367 1Scientists track impact of DNA damage in the developing brain 9364 1Scientists track impact of DNA damage in the developing brain 9364 2Scientists track impact of DNA damage in the developing brain 9364 3
...n spreads faster than it takes to diagnose it in t...e University have developed a test to bring,that t...assistant professor, and Greg Peterson, research,m...c medicine and,pathobiology, use a device called a...enetic markers that set one pathogen apart from an...
... NVAX ) today announced that the Company will hold...om the Phase I/IIa human clinical,trial of Novavax...t 11:00,a.m. Eastern Time on August 26, 2008., Th...ef Executive,Officer Dr. Rahul Singhvi and other m...al Officer, Dr. Penny Heaton. A question and answe...
Other Medicine Technology:Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 2
(Date:11/9/2009)...on could boost self-esteem, researchers say , ...c children are more likely to have handwriting pro...se without autism, researchers say. , The new s...he study participants had autism spectrum disorder... range for perceptual reasoning on an IQ test. ,...
(Date:11/9/2009)...regained sexual function, study says, , ...s were able to restore sexual function to rabbits ...in the lab and implanting it, a new study reports....searchers say the technique could one day be used ..."We were able to show the tissue was able to integ...
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
...patients informed about being paid to enrol them i... phase 4 clinical trials - are a signicnificant pa...s a new drug// and the family doctor reporting any...ortant way of revealing uncommon side effects. ...
...researchers have found that bone loss can be treme...t for kidney stones has the spin-off of increasing... a treatment// for kidney stones. Hence it has bee... a period ranging from 10 to 110 months to prevent...
...are protective substances, produced by the body in...ill the TB bacteria, researchers in the UK report....urnal Nature Medicine,// these heat-shock proteins...aham R. Stewart, of Imperial College of Science Te...
...merican women who are health have increased risk o...research on risk factors for heart disease and str...ia University report on how cholesterol and other ...5 years. The women were followed up for several ye...
... recent study shows that a leaky heart valve raise...brillation (AF) the upper chambers of the heart be...inked to heart attack and stroke.// Researchers at...flows backwards into the upper chamber in people w...
...ew bandages developed by US researchers take an ac...ice show that hydrogel bandages speed up healing.T...and six times and become pliable when wet.// Unlik... The researchers believe that the bandages will...
Other Medicine News:
Agarose,separation < 500 bp
...on of agar. Forms gel with superior mechanical qua...on microscope slides or transparent plastic. When ...le or no deterioration on staining with either pro...lling temperature: 42°C. Soluble in Hot H 2 O....
...s and instruments designed to perform the main tes... blood transfusion centers. The system is based ad... or the analysis of digitized images. The quality ...bulin reagents used gives the system an excellent ...
...0 Automated Microplate System, the PK CMV-PA Syste...for the detection of cytomegalovirus. Relative sen...red to EIA measures 99.8% and 99.3% respectively. ...des excellent lot-to-lot consistency and eliminate...
Medicine Products: